A patient with a history of asthma presents with increased frequency and severity of asthma attacks, nocturnal symptoms, elevated respiratory rate, and low oxygen saturation. Despite medication adherence, the condition is worsening. Given these symptoms, which nursing intervention is the priority?

C) Administer nebulized bronchodilator treatment as prescribed

A) Encourage the patient to use a rescue inhaler as needed

B) Educate the patient on relaxation techniques to reduce anxiety

C) Administer nebulized bronchodilator treatment as prescribed

D) Prepare the patient for possible mechanical ventilation

A patient with worsening asthma presents with increased wheezing, use of accessory muscles, and an oxygen saturation of 88% on room air. Which intervention should the nurse prioritize to prevent respiratory failure?

D) Initiate a nebulized bronchodilator treatment immediately

A) Administer a systemic corticosteroid as prescribed

B) Provide supplemental oxygen to maintain saturation levels above 92%

C) Encourage deep breathing and coughing exercises

D) Initiate a nebulized bronchodilator treatment immediately

A patient with asthma exacerbation is receiving systemic corticosteroids and nebulized bronchodilators. The patient shows initial improvement but develops tachycardia and elevated blood pressure. What is the priority nursing intervention?

B) Monitor the patient's cardiovascular status closely and administer a low-dose beta-blocker as prescribed.

A) Increase the dose of nebulized bronchodilators to enhance respiratory function.

B) Monitor the patient's cardiovascular status closely and administer a low-dose beta-blocker as prescribed.

C) Discontinue the corticosteroids immediately to prevent further cardiovascular complications.

D) Encourage the patient to perform deep-breathing exercises to reduce anxiety and improve oxygenation.

A patient with asthma is being treated with systemic corticosteroids and nebulized bronchodilators, showing signs of improvement. However, she develops tachycardia and elevated blood pressure. Which nursing intervention should be prioritized to address these new symptoms while managing her asthma effectively?

B) Administer a low-dose beta-blocker as ordered and educate the patient on potential side effects.

A) Continue the current treatment plan and monitor for further cardiovascular changes.

B) Administer a low-dose beta-blocker as ordered and educate the patient on potential side effects.

C) Increase the dose of systemic corticosteroids to reduce respiratory inflammation.

D) Discontinue the nebulized bronchodilators to prevent further cardiovascular complications.

A patient receiving systemic corticosteroids for asthma management develops peripheral edema and elevated creatinine levels, suggesting renal stress. What is the most appropriate nursing intervention to address this complication?

B) Encourage the patient to reduce sodium intake to decrease fluid retention.

A) Increase the patient's fluid intake to promote renal function.

B) Encourage the patient to reduce sodium intake to decrease fluid retention.

C) Discontinue all medications immediately to prevent further renal damage.

D) Advise the patient to rest and avoid physical activity to reduce stress on the kidneys.

A patient with asthma on systemic corticosteroids begins to exhibit peripheral edema and a mild elevation in creatinine levels. Which nursing intervention is most appropriate to address these symptoms while managing her asthma effectively?

C) Taper corticosteroids and increase nebulized bronchodilator frequency.

A) Increase her corticosteroid dose to reduce inflammation.

B) Initiate diuretic therapy immediately to manage fluid retention.

C) Taper corticosteroids and increase nebulized bronchodilator frequency.

D) Discontinue corticosteroids and switch to oral bronchodilators.

A patient with a history of asthma and recent renal stress is showing signs of peripheral edema improvement and increased urine output but presents with elevated heart rate and blood pressure. What is the most appropriate nursing intervention to address the cardiovascular changes observed in this patient?

B) Encourage the patient to maintain a low-sodium diet to help manage blood pressure.

A) Increase the frequency of bronchodilator treatments to improve respiratory function.

B) Encourage the patient to maintain a low-sodium diet to help manage blood pressure.

C) Administer an additional dose of diuretics to reduce fluid retention and lower blood pressure.

D) Withhold the patient's bronchodilator medication to reduce potential cardiovascular side effects.

A patient with asthma is experiencing an increased heart rate and elevated blood pressure while on bronchodilator therapy. Which intervention should the nurse prioritize to address these cardiovascular changes?

B) Monitor the patient's electrolyte levels, focusing on potassium and magnesium.

A) Encourage the patient to increase fluid intake to manage heart rate.

B) Monitor the patient's electrolyte levels, focusing on potassium and magnesium.

C) Suggest the patient reduce physical activity to minimize cardiovascular strain.

D) Advise the patient to stop using bronchodilator therapy immediately.

A patient with a history of asthma and recent cardiovascular adjustments is experiencing increased asthma exacerbations and hypokalemia. As a nurse, which intervention should be prioritized to address the patient's current condition?

B) Administer potassium supplements to correct the hypokalemia.

A) Increase the frequency of bronchodilator use to manage respiratory symptoms.

B) Administer potassium supplements to correct the hypokalemia.

C) Reduce the patient's diuretic dosage to minimize electrolyte imbalance.

D) Schedule an immediate follow-up spirometry test to assess lung function.

A patient with asthma and recent cardiovascular adjustments presents with hypokalemia and increased asthma exacerbations. The healthcare team plans to optimize her bronchodilator regimen and includes potassium supplements in the treatment plan. Which nursing intervention is most important to prioritize to prevent further complications?

A) Monitor the patient's serum potassium levels regularly and educate her on potassium-rich dietary choices.

B) Increase the frequency of bronchodilator administration to ensure better asthma control.

C) Advise the patient to avoid all physical exertion to prevent asthma exacerbations.

D) Instruct the patient to reduce fluid intake to prevent further electrolyte imbalances.

asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Asthma is characterized by chronic inflammation of the airways, leading to hyperresponsiveness. This inflammation causes the airways to react strongly to various triggers, resulting in bronchoconstriction, increased mucus production, and airway edema.

• Secondary mechanism: The immune system's overreaction involves key cells like eosinophils, mast cells, and T-lymphocytes. These cells release inflammatory mediators such as histamines and leukotrienes, which further exacerbate airway narrowing and obstruction.

• Key complication: Persistent inflammation and airway remodeling can result in decreased lung function over time, leading to frequent and severe asthma exacerbations, impacting a patient's quality of life and potentially leading to respiratory failure if not managed properly.

Patient Profile

Demographics:

28-year-old female, office worker

History:

• Key past medical history: Diagnosed with asthma at age 15, occasional eczema

• Current medications: Fluticasone/salmeterol inhaler, albuterol inhaler as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath over the past week

• Key symptoms: Wheezing, persistent cough, tightness in chest, occasional night waking due to breathing difficulty

• Vital signs: Blood pressure 145/95 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, oxygen saturation 92% on room air, temperature 37.2°C (99°F)

Section 1

New Complications:

Over the following days, the patient's condition began to deteriorate despite adherence to her prescribed medication regimen. She reported an increase in the frequency and severity of her asthma attacks, particularly at night, and a noticeable increase in fatigue during the day. Her respiratory rate remained elevated at 26 breaths per minute, and her oxygen saturation dropped to 88% on room air. A repeat physical examination revealed increased wheezing throughout all lung fields and the presence of accessory muscle use, indicating increased respiratory effort. The patient also exhibited signs of anxiety, likely stemming from her difficulty breathing and the fear of not getting enough air.

In light of these developments, additional diagnostic testing was conducted to further assess the extent of her condition. A chest X-ray ruled out pneumonia but showed signs of hyperinflation, suggesting air trapping commonly seen in asthma exacerbations. A complete blood count revealed an elevated eosinophil count, indicative of ongoing allergic inflammation. The decision was made to perform a peak flow measurement, which showed a significant reduction from her personal best, confirming a worsening of her asthma control.

Recognizing the potential for impending respiratory failure, the healthcare team initiated a more aggressive treatment plan. This included administering systemic corticosteroids to reduce airway inflammation and a nebulized bronchodilator treatment to alleviate bronchospasm. Continuous monitoring of her oxygen saturation and vital signs was implemented to ensure prompt intervention should her condition further decline. Close observation and timely adjustments to her management plan were critical in preventing further complications and improving her respiratory status. The team also considered adjusting her long-term asthma management strategy to achieve better control and reduce future exacerbations.

Section 2

In response to the aggressive treatment plan, the patient's condition showed initial signs of improvement. Her respiratory rate decreased to 22 breaths per minute, and her oxygen saturation improved to 92% with supplemental oxygen via nasal cannula. The systemic corticosteroids and nebulized bronchodilator treatments alleviated some of her respiratory distress, as evidenced by a reduction in wheezing and decreased use of accessory muscles. However, the patient continued to experience significant fatigue and reported intermittent episodes of anxiety, particularly when trying to sleep, which suggested that her symptoms were not yet fully controlled.

Despite these initial improvements, a follow-up assessment revealed new complications. The patient developed tachycardia, with a heart rate of 110 beats per minute, potentially linked to the systemic corticosteroids or anxiety. Additionally, her blood pressure rose to 150/95 mmHg, raising concerns about the cardiovascular side effects of her treatment. Given these findings, the healthcare team considered the balance between managing her respiratory symptoms and minimizing adverse effects. They initiated a low-dose beta-blocker to address the tachycardia while monitoring her blood pressure closely.

The patient's laboratory results also showed a persistent elevation in eosinophil count, suggesting that allergic inflammation was still a significant factor in her asthma exacerbation. This prompted the team to explore potential environmental or allergen triggers, encouraging the patient to maintain an asthma diary to identify any patterns or exposures that could be contributing to her condition. The team also planned to reassess her asthma action plan, ensuring it was comprehensive and tailored to her evolving needs. As the patient continued her recovery, the focus remained on refining her long-term management strategy to prevent future exacerbations and improve her overall quality of life.

Section 3

As the patient's treatment continued, the healthcare team noted a new complication that warranted further investigation. During a routine assessment, the patient began to exhibit subtle signs of peripheral edema, particularly in the lower extremities. This development raised concerns about potential fluid retention, possibly exacerbated by the systemic corticosteroids she was receiving. Her urine output decreased slightly, and a subsequent renal function panel revealed a mild elevation in creatinine levels, suggesting that her kidneys might be under stress. Recognizing the importance of maintaining renal function, the team decided to adjust her fluid balance management and consider diuretic therapy if necessary.

In light of these findings, the patient's medication regimen was carefully reviewed. The team decided to taper the corticosteroids more rapidly to mitigate their side effects while simultaneously increasing the frequency of her nebulized bronchodilator treatments to maintain control of her asthma symptoms. Furthermore, they engaged the patient in discussions about her lifestyle and dietary habits, emphasizing the importance of reducing sodium intake to help manage her blood pressure and potential fluid retention.

Throughout this phase of her care, the patient was closely monitored for any further changes in her condition. The healthcare team encouraged her to remain diligent in documenting her symptoms and any environmental factors in her asthma diary. They also scheduled regular follow-up appointments to reassess her renal function, cardiovascular status, and overall response to the modified treatment plan. By addressing these new complications proactively, the team aimed to stabilize her condition, prevent further exacerbations, and optimize her long-term quality of life.

Section 4

The healthcare team closely monitored the patient's response to the adjusted treatment plan and noted some encouraging initial changes. Within a week, there was a slight improvement in her peripheral edema, and her lower extremities appeared less swollen during physical assessment. Her urine output began to increase gradually, indicating a positive response to the fluid balance adjustments. However, the follow-up renal function panel showed only a modest improvement in creatinine levels, remaining slightly elevated at 1.4 mg/dL compared to the baseline of 1.1 mg/dL. While these results suggested some renal stress persisted, they were cautiously optimistic about her progress.

During this period, the patient also experienced a minor increase in her heart rate, averaging around 96 beats per minute, which was higher than her baseline of 78 beats per minute. Blood pressure readings were consistently slightly elevated at 140/88 mmHg. These cardiovascular changes prompted the team to consider a more comprehensive cardiovascular assessment to rule out any emerging complications related to the increased use of bronchodilators and potential fluid retention. They initiated a plan to conduct an echocardiogram and monitor her electrolytes closely, focusing on potassium and magnesium levels due to the potential impacts of both her medications and dietary adjustments.

Although the patient reported feeling somewhat fatigued, she remained engaged in her care plan and diligently documented her symptoms and any triggers in her asthma diary. She noted that her asthma symptoms were well-managed with the increased frequency of nebulized bronchodilator treatments, experiencing fewer nocturnal awakenings due to breathlessness. The team continued to emphasize lifestyle modifications, particularly emphasizing the importance of a low-sodium diet and regular physical activity tailored to her energy levels. These strategies aimed to support not only her respiratory health but also her cardiovascular and renal function as they worked toward stabilizing her overall condition.

Section 5

As the healthcare team continued to monitor the patient's progress, they noted a new complication: an increase in the frequency of her asthma exacerbations. Despite the initial improvement in nocturnal symptoms, the patient began to experience shortness of breath and wheezing during mild exertion, such as walking short distances. These episodes were accompanied by a noticeable increase in her respiratory rate, averaging 24 breaths per minute. Auscultation of her lungs revealed diffuse wheezing, particularly in the upper lobes, which was a change from her previous assessments. These findings suggested a possible worsening of her asthma control, potentially linked to the recent cardiovascular adjustments and increased bronchodilator use.

Laboratory tests revealed that the patient's serum potassium level had decreased to 3.2 mEq/L, below the normal range of 3.5 to 5.0 mEq/L. This hypokalemia was concerning, given the potential for it to exacerbate both respiratory and cardiac symptoms. The healthcare team hypothesized that the combination of dietary changes, increased diuretic use, and the effects of bronchodilators might have contributed to this electrolyte imbalance. In response, they promptly adjusted her treatment plan to include potassium supplements and advised the patient to incorporate potassium-rich foods into her diet, such as bananas and spinach, while maintaining a low-sodium intake.

The team also revisited her asthma management strategy, considering the possibility that her current bronchodilator regimen might need further optimization. They scheduled a follow-up spirometry test to assess her pulmonary function more precisely and engaged the patient in discussions about potential triggers she might have overlooked in her diary. As they addressed these new challenges, the healthcare providers remained vigilant, understanding that maintaining a delicate balance between respiratory, cardiovascular, and renal health was crucial for the patient's overall stability and quality of life.